A kaleidoscope of industries has emerged as early winners from the Trump administration’s health regulation overhaul.

FDA scientists found only rat data on the seven peptides Kennedy's panel votes on this week — and seven advisers sell the products themselves.

A kaleidoscope of industries has emerged as early winners from the Trump administration’s health regulation overhaul.